All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
KCE Reports 231 (2014)
KCE Reports 274 (2016) Supplementary material pdf fichierR274_Supplementary-file_Univariate-sensitivity-analyses (13.95 Mo) pdf fichierR274_Supplementary-file_Sensitivity-analyses_PPV23-price (1.1 Mo) pdf fichierR274_Supplementary-file_Multivariate-sensitivity-analyses_Net-benefit-Box-plots (1.16 Mo) pdf fichierR274_Supplementary-file_Multivariate-sensitivity-analyses_CEAFs-and-CE-planes (58.74 Mo) The results are also available in a searchable spreadsheet-database format for all scenario and sensitivity analyses.
KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.